Clinical Outcomes of Ileostomy Closure before Adjuvant Chemotherapy after Rectal Cancer Surgery: An Observational Study from a Chinese Center

Table 4

Details of LARS at follow-up 12 months after index surgery.

	Group I ()	Group II ()	Group III ()	value
12-month median LARS scores (IQR)	17 (6-29)	24 (14-32)	20 (8-31)	0.282
Major LARS, (%)	5 (25.0%)	14 (33.3%)	14 (31.8%)	0.796
Minor LARS, (%)	5 (25.0%)	9 (21.4%)	7 (15.9%)	0.660
Incontinence to feces, (%)	8 (40.0%)	19 (45.2%)	15 (31.4%)	0.572
Flatus, (%)	1 (5.0%)	3 (7.1%)	5 (11.4%)	0.644
Increased stool frequency, (%)	10 (50.0%)	28 (66.7%)	21 (47.7%)	0.179
Clustering, (%)	14 (70.0%)	36 (85.7%)	30 (68.2%)	0.138
Urgency, (%)	10 (50.0%)	27 (64.3%)	26 (59.1%)	0.563

Values are presented as the number of patients (%). LARS: low anterior resection syndrome; IQR: interquartile range.